| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/03/1994 | WO1994002018A1 Peptides capable of controlling acrosome reaction |
| 02/03/1994 | WO1994002015A1 Method of preserving platelets |
| 02/03/1994 | WO1993024096A3 Use of n-(2-(dimethylamino)ethyl)acridine-4-carboxamide and its analogues for cancer treatment |
| 02/03/1994 | WO1993021321A3 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/03/1994 | DE4227454C1 Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens Methods for early detection, to detect the severity and therapy-accompanying assessment of sepsis and means for carrying out the method |
| 02/03/1994 | CA2149146A1 Biologically active agent having immuno-modulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | CA2149121A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |
| 02/03/1994 | CA2140931A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune disease and tumour progression |
| 02/03/1994 | CA2140924A1 Bis-staurosporine and k-252a derivatives |
| 02/03/1994 | CA2140760A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | CA2140630A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | CA2140445A1 Procede d'administration de solutions de facteur de stimulation des colonies granulocytaires |
| 02/03/1994 | CA2140427A1 A two component fibrin-glue composition for improving in vitro fertilization |
| 02/03/1994 | CA2140343A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | CA2140151A1 Peptides that mimic gp120 hiv epitope |
| 02/03/1994 | CA2140132A1 Carboxy terminal il-6 muteins |
| 02/03/1994 | CA2140033A1 Peptide medicaments for treating disease |
| 02/03/1994 | CA2139517A1 Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
| 02/03/1994 | CA2137558A1 Method of intracellular binding of target molecules |
| 02/03/1994 | CA2120014A1 Peptides capable of controlling acrosome reaction |
| 02/03/1994 | CA2118588A1 Neuromedin b receptor antagonists |
| 02/02/1994 | EP0581429A2 Process for synthesizing cyclic depsipeptides |
| 02/02/1994 | EP0581108A2 Bispecific antibody reactive with sialyl-Lea antigen and CD3 |
| 02/02/1994 | EP0580874A1 Remedy for airway diseases |
| 02/02/1994 | EP0580829A1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract |
| 02/02/1994 | EP0580795A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| 02/02/1994 | EP0580790A1 Method for potentiating primary drugs in treating multidrug resistant cells |
| 02/02/1994 | EP0580782A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 02/02/1994 | EP0580778A1 Convertible microemulsion formulations |
| 02/02/1994 | EP0580774A1 Vitamin d derivatives comprising a lateral chain expoxide group |
| 02/02/1994 | EP0580763A1 Compositions and methods for endothelial binding |
| 02/02/1994 | EP0580758A1 Anti-human immunodeficiency virus recombinant antibodies |
| 02/02/1994 | EP0580752A1 Human bone derived insulin like growth factor binding protein |
| 02/02/1994 | EP0580694A1 Production of phosphopeptides from casein |
| 02/02/1994 | EP0580685A1 Pharmaceutical packaging unit containing plasminogen activators for multiple-bolus administration. |
| 02/02/1994 | EP0580594A1 New inhibitors of endothelial cell proliferation |
| 02/02/1994 | EP0290446B1 Vaccines for human respiratory virus |
| 02/02/1994 | EP0246307B1 Cys codon-modified dna |
| 02/02/1994 | CN1081378A Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
| 02/01/1994 | USH1286 Administering an anticholesterol agents which is an enzyme inhibitor of angiotensin converting enzyme or/and squalene synthetase |
| 02/01/1994 | US5283317 Water soluble adduct of superoxide dismutase |
| 02/01/1994 | US5283241 Animal growth regulators |
| 02/01/1994 | US5283238 Methods of treating cancer using modified C-reactive protein |
| 02/01/1994 | US5283236 Systemic delivery of polypeptides through the eye |
| 02/01/1994 | US5283191 Mareks' disease virus vaccine |
| 02/01/1994 | US5283058 Preventing the cytolysis of lymphocyte by alternating the antigen on donor's cell |
| 02/01/1994 | CA1326737C Phosphinic acid derivatives |
| 02/01/1994 | CA1326640C Bacterial strains |
| 02/01/1994 | CA1326639C Nucleic acid encoding tgf-.beta. and its uses |
| 01/31/1994 | CA2101614A1 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 01/31/1994 | CA2101468A1 Composition for isolating apamin receptors, apamin binding protein, and uses thereof |
| 01/30/1994 | CA2101348A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 01/29/1994 | CA2101350A1 Peptides derived from trifluoromethylketones, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/1994 | CA2074790A1 Methods for detecting pre-clinical iddm |
| 01/27/1994 | DE4324859A1 Oral compsn. for treating periodontal disease - contg. antibody obtd. by immunising animal with surface polysaccharide from pathogenic bacteria |
| 01/27/1994 | DE4224509A1 Agent for inhibiting liver cell proliferation - comprising seryl-aspartyl-lysine tri:peptide, useful for treating liver diseases |
| 01/27/1994 | DE4224357A1 Compsn. for prophylaxis of the haemolytic disease of the new-born |
| 01/26/1994 | EP0580161A1 Prophylactic and therapeutic treatment of Alzheimer's disease |
| 01/26/1994 | EP0580008A2 Phenylimidazolidine Derivatives, their preparation and use |
| 01/26/1994 | EP0579958A1 A preventive or therapeutic medicine for pancreatitis |
| 01/26/1994 | EP0579830A1 Therapeutic agent for corneal lesion |
| 01/26/1994 | EP0579826A1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
| 01/26/1994 | EP0579823A1 New hexapeptidic derivatives, preparation, method and application as medicaments of said new derivatives |
| 01/26/1994 | EP0579791A1 Cellular composition for the treatment of human or animal organisms |
| 01/26/1994 | EP0579771A1 Single-stranded circular oligonucleotides |
| 01/26/1994 | EP0579765A1 Method and composition for the treatment of herpes related disorders |
| 01/26/1994 | EP0579763A1 Novel peptide compositions and uses therefor |
| 01/26/1994 | EP0579758A1 Parathyroid hormone receptor and dna encoding same |
| 01/26/1994 | EP0579747A1 Method of modulating mammalian t-cell response |
| 01/26/1994 | EP0579742A1 Product and method for improving keratinocyte adhesion to the dermis |
| 01/26/1994 | EP0579739A1 Interleukin-8 receptors and related molecules and methods |
| 01/26/1994 | EP0579709A1 A plant chitinase gene and use thereof |
| 01/26/1994 | EP0579640A1 Glial mitogenic factors, their preparation and use |
| 01/26/1994 | EP0579626A1 Method and agents for promoting wound healing |
| 01/26/1994 | EP0579611A1 Peptides |
| 01/26/1994 | EP0579602A1 Vasopressin and vasotocin derivates |
| 01/26/1994 | EP0470117B1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
| 01/26/1994 | EP0428573B1 Method and compositions for the treatment and prevention of septic shock |
| 01/26/1994 | EP0424512B1 Antimetastatic peptides |
| 01/26/1994 | EP0423301B1 Synthetic peptides of the conjugate of ubiquitine and histone h2a |
| 01/26/1994 | EP0419504B1 Insulin analogues |
| 01/26/1994 | EP0417165B1 Polypeptide compounds having growth hormone releasing activity |
| 01/26/1994 | EP0382841B1 Wound healing |
| 01/26/1994 | EP0314781B1 Synthesis of glucagon homologs and therapeutic use thereof |
| 01/26/1994 | EP0272304B1 A process for producing a coagulation active complex of factor viii fragments |
| 01/25/1994 | US5281717 Pharmaceuticals |
| 01/25/1994 | US5281699 Treating B cell lymphoma or leukemia by targeting specific epitopes on B cell bound immunoglobulins |
| 01/25/1994 | US5281697 CEA-binding protein and uses thereof |
| 01/25/1994 | US5281661 Contacting aqueous conductive mixture with carrier based on a polymer containing hydrophobic groups to complex factor XI |
| 01/25/1994 | US5281616 Porphyrin and phthalocyanine antiviral compositions |
| 01/25/1994 | US5281582 Glycosylated albumin growth factor for tissue treatment |
| 01/25/1994 | US5281581 Treatment of insulin resistance |
| 01/25/1994 | US5281580 Respiratory system disorders |
| 01/25/1994 | US5281579 Purified virus-free hemoglobin solutions and method for making same |
| 01/25/1994 | US5281577 Inhibitor of the proliferation of herpes viruses and inhibitor of the recurrence of affections caused by their latent infection |
| 01/25/1994 | US5281526 Method of purification of amylase by precipitation with a metal halide and 4-hydroxybenzic acid or a derivative thereof |
| 01/25/1994 | US5281524 Activating cells of streptococcus mutans serotype c,e,or f, removing supernatant from culture, extracting cells with urea-containing solvent to break bonds between cells and glucosyltransferase |
| 01/25/1994 | US5281520 Isolated DNA molecule comprising DNA segment encoding avian or mammalian acyloxyacyl hydrolase free of other genes |
| 01/25/1994 | CA1326460C Regulation of cell proliferation and differentiation using peptides |
| 01/25/1994 | CA1326450C Modulation of aids virus-related events by double stranded rnas (dsrnas) |